Remove 2016 Remove Chemicals Remove Journalism Remove Technology
article thumbnail

Theranos: Triumph Of PR Over Science?

ImPRessions - Crenshaw Communications

The suddenly sober mood of 2016 is extending to Silicon Valley. ” The rise and fall of the once-promising health technology startup is a warning for investors chasing the next unicorn. One factor is the recent frothy environment for technology startups. Theranos was valued at an impressive $9 billion.